Franco Research Development vs Total Revenue Analysis

FNV Stock

USD 122.96 0.39 0.32%

Franco Nevada financial indicator trend analysis is much more than just examining Franco Nevada latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Franco Nevada is a good investment. Please check the relationship between Franco Nevada Research Development and its Total Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Franco Nevada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Franco Stock please use our How to Invest in Franco Nevada guide.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Franco Nevada Research Development account and Total Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Franco Nevada's Research Development and Total Revenue is 0.84. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Franco Nevada, assuming nothing else is changed. The correlation between historical values of Franco Nevada's Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Franco Nevada are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Franco Nevada's Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Franco Nevada generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Franco Nevada's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Franco Nevada current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Franco Nevada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Franco Stock please use our How to Invest in Franco Nevada guide.Enterprise Value is likely to climb to about 23.6 B in 2024, whereas Selling General Administrative is likely to drop slightly above 21.7 M in 2024.

	2021	2022	2024 (projected)
Interest Expense	300K	100K	2.9M
Depreciation And Amortization	297.0M	274.9M	207.0M

Interest Expense Depreciation And Amortization

Franco Nevada fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Long Term Investments
Total Assets		0.22	0.45	1.0	0.78	0.97	-0.32	0.56	0.27	0.35	0.96	-0.56	0.44	-0.45	0.32	0.86	0.96	0.94	0.38	0.28	-0.52	0.62	-0.29	0.34	-0.09	0.94
Other Current Liab	0.22		0.96	0.24	0.13	0.26	-0.34	0.14	0.1	0.29	0.11	-0.5	0.41	0.18	0.33	0.55	0.18	0.25	0.24	-0.28	0.13	0.14	0.16	-0.16	-0.27	0.01
Total Current Liabilities	0.45	0.96		0.47	0.33	0.48	-0.42	0.31	0.16	0.38	0.33	-0.59	0.51	0.05	0.41	0.73	0.4	0.44	0.3	-0.21	-0.02	0.32	0.11	-0.09	-0.28	0.26
Total Stockholder Equity	1.0	0.24	0.47		0.78	0.97	-0.36	0.57	0.27	0.37	0.95	-0.56	0.45	-0.46	0.34	0.86	0.96	0.94	0.38	0.2	-0.55	0.62	-0.27	0.27	-0.16	0.94
Other Liab	0.78	0.13	0.33	0.78		0.79	-0.67	0.72	0.09	0.73	0.67	-0.3	0.0	-0.49	0.7	0.71	0.7	0.67	0.28	0.19	-0.62	0.88	-0.23	0.23	-0.18	0.77
Net Tangible Assets	0.97	0.26	0.48	0.97	0.79		-0.45	0.49	0.26	0.47	0.87	-0.63	0.31	-0.35	0.45	0.88	0.97	0.93	0.29	0.23	-0.44	0.65	-0.2	0.29	-0.12	0.92
Net Debt	-0.32	-0.34	-0.42	-0.36	-0.67	-0.45		-0.6	0.06	-0.97	-0.07	0.23	0.16	0.08	-0.97	-0.52	-0.26	-0.22	-0.31	0.38	0.25	-0.6	-0.13	0.33	0.46	-0.29
Retained Earnings	0.56	0.14	0.31	0.57	0.72	0.49	-0.6		0.05	0.6	0.42	0.02	0.28	-0.4	0.59	0.63	0.35	0.29	0.7	0.01	-0.52	0.64	-0.1	0.05	-0.22	0.46
Accounts Payable	0.27	0.1	0.16	0.27	0.09	0.26	0.06	0.05		-0.05	0.3	-0.47	0.07	-0.05	-0.05	0.35	0.27	0.33	0.1	0.04	0.02	0.08	0.17	0.06	-0.01	0.16
Cash	0.35	0.29	0.38	0.37	0.73	0.47	-0.97	0.6	-0.05		0.1	-0.29	-0.2	-0.02	1.0	0.54	0.28	0.26	0.31	-0.17	-0.18	0.66	0.11	-0.13	-0.27	0.31
Non Current Assets Total	0.96	0.11	0.33	0.95	0.67	0.87	-0.07	0.42	0.3	0.1		-0.5	0.47	-0.52	0.07	0.72	0.93	0.94	0.27	0.37	-0.56	0.51	-0.36	0.42	-0.01	0.93
Non Currrent Assets Other	-0.56	-0.5	-0.59	-0.56	-0.3	-0.63	0.23	0.02	-0.47	-0.29	-0.5		-0.36	-0.33	-0.3	-0.71	-0.61	-0.7	-0.09	-0.16	-0.28	-0.26	-0.09	-0.23	-0.11	-0.43
Other Assets	0.44	0.41	0.51	0.45	0.0	0.31	0.16	0.28	0.07	-0.2	0.47	-0.36		0.02	-0.19	0.5	0.32	0.4	0.48	0.04	-0.02	0.01	-0.15	0.1	-0.04	0.3
Long Term Debt	-0.45	0.18	0.05	-0.46	-0.49	-0.35	0.08	-0.4	-0.05	-0.02	-0.52	-0.33	0.02		0.02	-0.1	-0.42	-0.35	-0.08	0.06	0.97	-0.32	0.38	0.06	0.34	-0.58
Cash And Short Term Investments	0.32	0.33	0.41	0.34	0.7	0.45	-0.97	0.59	-0.05	1.0	0.07	-0.3	-0.19	0.02		0.53	0.26	0.23	0.32	-0.19	-0.15	0.64	0.11	-0.14	-0.27	0.28
Net Receivables	0.86	0.55	0.73	0.86	0.71	0.88	-0.52	0.63	0.35	0.54	0.72	-0.71	0.5	-0.1	0.53		0.78	0.78	0.49	0.13	-0.21	0.63	-0.03	0.23	-0.13	0.68
Common Stock Total Equity	0.96	0.18	0.4	0.96	0.7	0.97	-0.26	0.35	0.27	0.28	0.93	-0.61	0.32	-0.42	0.26	0.78		0.96	0.19	0.27	-0.48	0.54	-0.26	0.33	-0.08	0.94
Common Stock Shares Outstanding	0.94	0.25	0.44	0.94	0.67	0.93	-0.22	0.29	0.33	0.26	0.94	-0.7	0.4	-0.35	0.23	0.78	0.96		0.21	0.3	-0.4	0.54	-0.37	0.36	-0.03	0.9
Short Term Investments	0.38	0.24	0.3	0.38	0.28	0.29	-0.31	0.7	0.1	0.31	0.27	-0.09	0.48	-0.08	0.32	0.49	0.19	0.21		0.04	-0.15	0.07	-0.08	0.08	-0.07	0.21
Non Current Liabilities Total	0.28	-0.28	-0.21	0.2	0.19	0.23	0.38	0.01	0.04	-0.17	0.37	-0.16	0.04	0.06	-0.19	0.13	0.27	0.3	0.04		0.11	0.18	-0.23	0.99	0.83	0.26
Inventory	-0.52	0.13	-0.02	-0.55	-0.62	-0.44	0.25	-0.52	0.02	-0.18	-0.56	-0.28	-0.02	0.97	-0.15	-0.21	-0.48	-0.4	-0.15	0.11		-0.45	0.35	0.11	0.47	-0.65
Other Current Assets	0.62	0.14	0.32	0.62	0.88	0.65	-0.6	0.64	0.08	0.66	0.51	-0.26	0.01	-0.32	0.64	0.63	0.54	0.54	0.07	0.18	-0.45		-0.29	0.22	-0.12	0.6
Other Stockholder Equity	-0.29	0.16	0.11	-0.27	-0.23	-0.2	-0.13	-0.1	0.17	0.11	-0.36	-0.09	-0.15	0.38	0.11	-0.03	-0.26	-0.37	-0.08	-0.23	0.35	-0.29		-0.22	-0.08	-0.33
Total Liab	0.34	-0.16	-0.09	0.27	0.23	0.29	0.33	0.05	0.06	-0.13	0.42	-0.23	0.1	0.06	-0.14	0.23	0.33	0.36	0.08	0.99	0.11	0.22	-0.22		0.81	0.3
Deferred Long Term Liab	-0.09	-0.27	-0.28	-0.16	-0.18	-0.12	0.46	-0.22	-0.01	-0.27	-0.01	-0.11	-0.04	0.34	-0.27	-0.13	-0.08	-0.03	-0.07	0.83	0.47	-0.12	-0.08	0.81		-0.09
Long Term Investments	0.94	0.01	0.26	0.94	0.77	0.92	-0.29	0.46	0.16	0.31	0.93	-0.43	0.3	-0.58	0.28	0.68	0.94	0.9	0.21	0.26	-0.65	0.6	-0.33	0.3	-0.09

Click cells to compare fundamentals

Franco Nevada Account Relationship Matchups

Franco Nevada fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.3B	5.6B	6.2B	6.6B	6.0B	4.3B
Other Current Liab	46.6M	37.3M	25.1M	36.1M	25.4M	28.7M
Total Current Liabilities	53.4M	53.2M	43.2M	50.2M	39.2M	36.7M
Total Stockholder Equity	5.1B	5.4B	6.0B	6.4B	5.8B	4.2B
Other Liab	85M	95.9M	141.5M	159M	182.9M	192.0M
Net Tangible Assets	5.1B	5.4B	6.0B	6.4B	7.4B	4.2B
Net Debt	(49.5M)	(529.8M)	(533.2M)	(1.2B)	(1.4B)	(1.4B)
Retained Earnings	(164.4M)	(34.4M)	484.9M	940.4M	212.3M	222.9M
Accounts Payable	6.8M	3.5M	8.5M	7M	5.5M	6.4M
Cash	132.1M	534.2M	539.3M	1.2B	1.4B	1.5B
Non Current Assets Total	5.0B	4.9B	5.5B	5.2B	4.4B	3.6B
Other Assets	43.3M	88.4M	66.2M	82.3M	(8.9M)	(8.4M)
Cash And Short Term Investments	132.1M	534.2M	539.3M	1.2B	1.4B	1.5B
Net Receivables	97.8M	93.4M	119.8M	135.7M	111M	80.8M
Common Stock Total Equity	5.1B	5.2B	5.4B	5.6B	6.4B	4.1B
Common Stock Shares Outstanding	188M	190.7M	191.5M	191.9M	192M	169.9M
Short Term Investments	13.4M	10.5M	9.6M	654.8M	(8.1M)	(7.7M)
Liabilities And Stockholders Equity	5.3B	5.6B	6.2B	6.6B	6.0B	4.3B
Non Current Liabilities Total	165M	95.9M	141.5M	159M	185.8M	131.7M
Inventory	7.1M	5.4M	4.4M	500K	100K	475K
Other Current Assets	26.9M	35.6M	91.8M	50.8M	81.9M	86.0M
Total Liab	218.4M	149.1M	184.7M	209.2M	225M	168.3M
Long Term Investments	145.6M	238.4M	235.1M	224.6M	246.4M	153.2M
Total Current Assets	278.7M	663.7M	751.4M	1.4B	1.6B	1.7B
Accumulated Other Comprehensive Income	(178.3M)	(115.9M)	(104.3M)	(233.7M)	(192.0M)	(182.4M)
Common Stock	5.4B	5.6B	5.6B	5.7B	5.7B	4.3B
Property Plant Equipment	4.8B	4.6B	5.2B	4.9B	5.7B	3.4B
Property Plant And Equipment Net	4.8B	4.6B	5.2B	4.9B	4.0B	3.6B
Property Plant And Equipment Gross	4.8B	4.6B	8.5B	8.5B	7.9B	4.3B
Short Long Term Debt Total	82.6M	4.4M	6.1M	6.0M	5.7M	5.4M
Net Invested Capital	5.1B	5.4B	6.0B	6.4B	5.8B	6.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Franco Stock Analysis

When running Franco Nevada's price analysis, check to measure Franco Nevada's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Franco Nevada is operating at the current time. Most of Franco Nevada's value examination focuses on studying past and present price action to predict the probability of Franco Nevada's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Franco Nevada's price. Additionally, you may evaluate how the addition of Franco Nevada to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC